Clinical Trial Update: The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of oxaliplatin and S-1 for gastric cancer has completed, reporting efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED